Loading...
CBIO-02. AMPLIFIED EGFR DRIVES TUMORIGENESIS IN TP53 WILD TYPE GLIOBLASTOMA THROUGH INHIBITION OF p53 FUNCTION BY DNA-PK/p53 BINDING
Epidermal growth factor receptor (EGFR) amplification/mutation and TP53 mutation are two most frequent genetic events that differentiate molecular subtypes of Glioblastoma. An extensive analysis of the Glioblastoma TCGA database showed a near exclusivity between p53 mutation and EGFR amplification i...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5691886/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.125 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|